Antidepressant Use During Pregnancy and the Rates of Spontaneous Abortions: A Meta-Analysis

• Published in: The Annals of pharmacotherapy 2005-05, Vol.39 (5), p.803-809
• Main Authors: Hemels, Michiel EH, Einarson, Adrienne, Koren, Gideon, Lanctot, Krista L, Einarson, Thomas R
• Format: Article
• Language: English
• Subjects: Abortion, Spontaneous - chemically induced; Antidepressive Agents - adverse effects; Antidepressive Agents - classification; Biological and medical sciences; Depression - drug therapy; Diseases of mother, fetus and pregnancy; Drug toxicity and drugs side effects treatment; Female; Gynecology. Andrology. Obstetrics; Humans; Medical sciences; Miscellaneous (drug allergy, mutagens, teratogens...); Pharmacology. Drug treatments; Pregnancy; Pregnancy Complications - drug therapy; Pregnancy. Fetus. Placenta
• ISSN: 1060-0280; 1542-6270
• DOI: 10.1345/aph.1E547

BACKGROUND: Due to the high prevalence of depression in women of childbearing age and coupled with the fact that approximately 50% of the pregnancies are unplanned, there is a high chance that these women have been exposed to antidepressants in early pregnancy. OBJECTIVE: To determine baseline rates of spontaneous abortions (SAs) and whether antidepressants increase those rates. METHODS: Rates of SAs in women taking antidepressants compared with non-depressed women were combined into a relative risk using a random effects model. MEDLINE, EMBASE, Healthstar, Toxline, Psychlit, Cochrane database, and Reprotox were searched for studies published in any language from 1966 to 2003. Key words used to identify articles included pregnancy outcome, abortion, miscarriage, spontaneous, antidepressant, depression, and the generic names of each antidepressant and class. Bibliographies, review articles, and reference lists from studies were also used to identify potential articles expected to provide evidence of safety of antidepressants in pregnancy. RESULTS: Of 15 potential articles, 6 cohort studies of 3567 women (1534 exposed, 2033 nonexposed) provided extractable data. All matched on important confounders. Tests found no heterogeneity (χ2 3.13; p = 0.98), and all quality scores were adequate (>50%). The baseline SA rate (95% CI) was 8.7% (7.5% to 9.9%; n = 2033). For antidepressants, the rate was 12.4% (10.8% to 14.1%; n = 1534), significantly increased by 3.9% (1.9% to 6.0%); RR was 1.45 (1.19 to 1.77; n = 3567). No differences were found among antidepressant classes. CONCLUSIONS: Maternal exposure to antidepressants may be associated with increased risk for SA; however, depression itself cannot be ruled out.